Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanara MedTech Inc.

32.89
+0.65002.02%
Pre-market: 31.71-1.1800-3.59%04:11 EDT
Volume:21.91K
Turnover:712.93K
Market Cap:292.33M
PE:-28.87
High:33.14
Open:32.55
Low:32.00
Close:32.24
Loading ...

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

GlobeNewswire
·
11 Apr

Sanara MedTech (SMTI) Stock Jumps 8.1%: Will It Continue to Soar?

Zacks
·
10 Apr

Sanara MedTech Price Target Maintained With a $46.00/Share by Cantor Fitzgerald

Dow Jones
·
26 Mar

Sanara MedTech Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
26 Mar

Sanara MedTech Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
26 Mar

Sanara MedTech Shares Fall on Wider 4Q Loss

Dow Jones
·
25 Mar

Sanara Medtech Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
25 Mar

Sanara MedTech Q4 2024 GAAP EPS $(0.18) Misses $(0.12) Estimate, Sales $26.305M Beat $25.800M Estimate

Benzinga
·
25 Mar

Sanara Medtech Inc: Qtrly Net Revenue $26.3 Mln

THOMSON REUTERS
·
25 Mar

Sanara Medtech Inc: Qtrly Shr Loss $0.18

THOMSON REUTERS
·
25 Mar

Sanara Medtech FY Revenue USD 86.7 Million

THOMSON REUTERS
·
25 Mar

Sanara Medtech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)

THOMSON REUTERS
·
25 Mar

Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)

GlobeNewswire
·
25 Mar

Sanara Medtech Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
21 Mar

Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

GlobeNewswire
·
12 Mar

Investors in Sanara MedTech (NASDAQ:SMTI) have seen strong returns of 215% over the past five years

Simply Wall St.
·
03 Mar

Biomimetic Innovations Ltd, an Affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment With Sanara Medtech Inc.

THOMSON REUTERS
·
24 Jan

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

GlobeNewswire
·
24 Jan

Sanara MedTech Price Target Maintained With a $44.00/Share by Cantor Fitzgerald

Dow Jones
·
23 Jan

Sanara MedTech Reports Q4 Preliminary Revenue Rose; Elizabeth Taylor Named CFO

MT Newswires Live
·
22 Jan